CA2252573A1 - Composes heterocycliques - Google Patents
Composes heterocycliques Download PDFInfo
- Publication number
- CA2252573A1 CA2252573A1 CA002252573A CA2252573A CA2252573A1 CA 2252573 A1 CA2252573 A1 CA 2252573A1 CA 002252573 A CA002252573 A CA 002252573A CA 2252573 A CA2252573 A CA 2252573A CA 2252573 A1 CA2252573 A1 CA 2252573A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- compounds
- group
- azabicyclo
- octyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des composés hétérocycliques utiles pour la modulation d'un récepteur muscarinique.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1600596P | 1996-04-23 | 1996-04-23 | |
US60/016,005 | 1996-04-23 | ||
PCT/US1997/006678 WO1997039753A1 (fr) | 1996-04-23 | 1997-04-23 | Composes heterocycliques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2252573A1 true CA2252573A1 (fr) | 1997-10-30 |
Family
ID=21774835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002252573A Abandoned CA2252573A1 (fr) | 1996-04-23 | 1997-04-23 | Composes heterocycliques |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0912183A4 (fr) |
JP (1) | JP2000509043A (fr) |
AU (1) | AU2738397A (fr) |
CA (1) | CA2252573A1 (fr) |
WO (1) | WO1997039753A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6737154B2 (en) * | 1995-06-26 | 2004-05-18 | 3M Innovative Properties Company | Multilayer polymer film with additional coatings or layers |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4555521A (en) * | 1983-11-16 | 1985-11-26 | Fmc Corporation | Nematicidal 3-substituted-4-phenyl-1,2,5-thiadiazoles |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
US5929247A (en) * | 1994-10-24 | 1999-07-27 | Eli Lilly And Company | Heterocyclic compounds and their preparation and use |
US6040442A (en) * | 1995-06-01 | 2000-03-21 | Eli Lilly And Company | Process for preparing 1,2,5-thiadiazole containing ethers |
US5767280A (en) * | 1995-06-01 | 1998-06-16 | Eli Lilly And Company | Process for making heterocyclic compounds |
-
1997
- 1997-04-23 EP EP97921314A patent/EP0912183A4/fr not_active Withdrawn
- 1997-04-23 AU AU27383/97A patent/AU2738397A/en not_active Abandoned
- 1997-04-23 CA CA002252573A patent/CA2252573A1/fr not_active Abandoned
- 1997-04-23 JP JP9538262A patent/JP2000509043A/ja active Pending
- 1997-04-23 WO PCT/US1997/006678 patent/WO1997039753A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0912183A1 (fr) | 1999-05-06 |
AU2738397A (en) | 1997-11-12 |
JP2000509043A (ja) | 2000-07-18 |
EP0912183A4 (fr) | 1999-08-04 |
WO1997039753A1 (fr) | 1997-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3100160B2 (ja) | 複素環式化合物、その調製方法およびその用途 | |
EP0687266B1 (fr) | Composes heterocycliques, preparation et utilisation | |
JP3100158B2 (ja) | 複素環化合物及びそれらの製造及び用途 | |
US5591755A (en) | Pyridinyl thiadiazolyl compounds for treating glaucoma | |
JPH04295477A (ja) | 緑内障処置のための置換ピラジン、ピリミジン、ピリダジン類 | |
JPH11508540A (ja) | 新規の置換アザ環式またはアザ二環式化合物 | |
JPH09501659A (ja) | 抗精神病方法 | |
RU2075479C1 (ru) | Арилоксиалкилгетероарил-8-азабицикло(3,2,1)октаны, способ их получения и гетероарил-8-азабицикло(3,2,1)октаны | |
EP1819709A1 (fr) | Nouveaux derives aryliques diazabicycliques utilises en tant que ligands cholinergiques | |
CA2252573A1 (fr) | Composes heterocycliques | |
US6117883A (en) | Heterocyclic compounds | |
JPH11512444A (ja) | 新規置換アザ環式またはアザ二環式化合物 | |
US6187798B1 (en) | Heterocyclic compounds | |
US6124312A (en) | Heterocyclic compounds | |
US6281232B1 (en) | Method of treating gastrointestinal motility disorders | |
US6069159A (en) | Heterocyclic compounds | |
JPH09507842A (ja) | 消化管運動機能障害の治療方法 | |
WO1999059995A1 (fr) | Composes heterocycliques, leur preparation et leur utilisation | |
US20010031751A1 (en) | Pharmaceuticals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |